Acting CDC Director Advocates for Separating MMR Vaccine into Individual Shots
Acting CDC Director Jim O'Neill has called for the development of separate vaccines for measles, mumps, and rubella, aligning with President Trump's recent statements, despite concerns from public health experts about the lack of scientific justification and potential impact on vaccination rates.
Acting Director of the Centers for Disease Control and Prevention (CDC), Jim O'Neill, has urged vaccine manufacturers to develop individual vaccines for measles, mumps, and rubella, replacing the current combined MMR vaccine. This call follows President Donald Trump's recent statement advocating for the separation of the MMR shot into three distinct vaccinations.
Public health experts have expressed concern over this proposal, noting that there is no scientific evidence supporting the separation of the MMR vaccine. They warn that such a move could lead to increased healthcare visits, reduced vaccine accessibility, and a decline in vaccination rates. The combined MMR vaccine has been in use since 1971 and is designed to streamline the immunization process, reducing the number of injections and ensuring timely protection against these diseases.
Currently, monovalent vaccines for measles, mumps, or rubella are not available in the United States. Developing and approving separate vaccines would require extensive clinical testing and regulatory review, a process that could take several years. Health authorities, including the CDC and the American Academy of Pediatrics, continue to recommend the combined MMR vaccine as the standard approach for immunization.
The CDC's Advisory Committee on Immunization Practices recently recommended against the use of the combined MMR and varicella (chickenpox) vaccine for children under four years old, due to an increased risk of febrile seizures. However, this recommendation does not extend to separating the MMR vaccine into individual components.
Experts caution that if vaccination rates decline, there could be a resurgence of measles, mumps, and rubella, diseases that have been largely controlled through widespread immunization efforts. Vulnerable populations, such as newborns, individuals with weakened immune systems, and older adults, would be at increased risk if community immunity diminishes.